Results from the International, Randomized Phase 3 Study of Ibrutinib Versus Chlorambucil in Patients 65 Years and Older with Treatment-Naïve CLL/SLL (RESONATE-2TM)
Year: 2015
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Blood
Authors: Alessandra Tedeschi, Paul M. Barr, Tadeusz Robak, Carolyn Owen, Paolo Ghia, Osnat Bairey, Peter Hillmen, Nancy L Bartlett, Jianyong Li, David Simpson, Sebastian Grosicki, Stephen Devereux, Helen McCarthy, Steven Coutre, Hang Quach, Gianluca Gaidano, Zvenyslava Maslyak, Don A. Stevens, Ann Janssens, Fritz Offner, Jiří Mayer, Michael O'Dwyer, Andrzej Hellmann, Anna Schuh, Tanya Siddiqi, Aaron Polliack, Constantine S. Tam, Michael Keating, Deepali Suri, Cathy Zhou, Fong Clow, Lori Styles, Danelle F. James, Thomas J. Kipps, Jan A. Burger
Institutions: Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, University of Rochester, Copernicus Memorial Hospital, Medical University of Lodz, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Tel Aviv University, Rabin Medical Center, Leeds Teaching Hospitals NHS Trust, Washington University in St. Louis, Jiangsu Province Hospital, North Shore Hospital, Medical University of Silesia, King's College Hospital, Royal Bournemouth Hospital, Stanford Medicine, Stanford University, The University of Melbourne, St Vincent's Hospital Melbourne, Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Institute of Blood Pathology and Transfusion Medicine of the National Academy of Medical Sciences of Ukraine, National Academy of Medical Sciences of Ukraine, Norton Healthcare, Universitair Ziekenhuis Leuven, Ghent University Hospital, University Hospital Brno, University Hospital Galway, University Clinical Centre, Gdańsk Medical University, University of Oxford, City Of Hope National Medical Center, Hebrew University of Jerusalem, Hadassah Medical Center, Peter MacCallum Cancer Centre, The University of Texas MD Anderson Cancer Center, Pharmacyclics (United States), Moores Cancer Center
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2473613583